Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials

Background: Chronic urticaria (CU) is a commonly seen skin disorder featured by recurring wheals, with or without angioedema, lasting for at least 6 weeks. Runzao Zhiyang capsule (RZC) has been widely applied to treat patients with CU. This study is aimed at systematically evaluating the efficacy an...

Full description

Bibliographic Details
Main Authors:	Jian-Feng Zhang, Ying-Dong Wang, Peng Lin, Jun-Chen Li, Chen-Qi Guo, Jing-Bo Zhai, Yu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Pharmacology
Subjects:	Runzao Zhiyang capsule chronic urticaria antihistamines randomized controlled trials meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1200252/full

Similar Items

Chronic urticaria: An overview
by: Yadav Sudha, et al.
Published: (2006-01-01)

A systematic review and meta-analysis of efficacy and safety of compound glycyrrhizin combined with second-generation non-sedated antihistamine for the treatment of chronic urticaria
by: Sijue Chen, et al.
Published: (2024-12-01)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
by: Staevska MT
Published: (2016-11-01)

Acute and Chronic Urticaria: Prevalence, Etiologies, Diagnosis, and Treatment
by: Javad Ghaffari, et al.
Published: (2020-07-01)

The Effect of Autologous Serum Therapy on Disease Severity in Patients with Chronic Urticaria
by: Farhad Abolnezhadian, et al.
Published: (2016-08-01)

ANTIHISTAMINES IN TREATMENT OF CHRONIC URTICARIA. REVIEW OF MODERN RECOMMENDATIONS
by: M. V. LEONOVA, et al.
Published: (2016-12-01)

Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?
by: Aleksandraviciute Laima, et al.
Published: (2021-12-01)

Real-life experience of efficacy and safety of bilastine in the refractory cases of chronic spontaneous urticaria and its effect on the quality of life of patients
by: Abhishek De, et al.
Published: (2021-01-01)

Up-dosing of non-sedating antihistamines in chronic urticaria: Need for well-designed clinical trials in India
by: Anant D Patil
Published: (2014-01-01)

The safety and tolerability profile of bilastine for chronic urticaria in children
by: Nikolaos G. Papadopoulos, et al.
Published: (2019-10-01)

Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients
by: Caroline Mann, et al.
Published: (2022-03-01)

Japanese Guidelines for Diagnosis and Treatment of Urticaria in Comparison with Other Countries
by: Michihiro Hide, et al.
Published: (2012-01-01)

Treatment of chronic urticaria with omalizumab: the experience of Hospital de Braga
by: Ana G. Lopes, et al.
Published: (2022-10-01)

Six Cases of Antihistamine-Resistant Dermographic Urticaria Treated with Oral Ciclosporin
by: Sayuri Toda, et al.
Published: (2011-01-01)

Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria
by: Giuseppe Fabio Parisi, et al.
Published: (2018-12-01)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
by: Elizabeth García-Gómez, et al.
Published: (2022-05-01)

Solar urticaria. Case report and literature review
by: María Raigoza, et al.
Published: (2017-10-01)

Evaluation of New Inflammatory Parameters in Patients With Chronic Spontaneous Urticaria: A New Predictor of Refractoriness to Antihistamine Treatment
by: Nur Cihan COSANSU
Published: (2020-12-01)

Educational level and job status are the most important factors affecting compliance with oral antihistamine therapy for patients with chronic urticaria
by: Neslihan Akdogan, et al.
Published: (2019-02-01)

Acute urticaria: differential diagnosis and treatment
by: Alexander N. Pampura, et al.
Published: (2021-03-01)

Bilastine up-dosing in chronic urticaria: A review
by: Kiran Godse, et al.
Published: (2022-01-01)

Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
by: Marysia Tiongco Recto, et al.
Published: (2017-11-01)

Variations of Thiol–Disulfide Homeostasis Parameters after Treatment with H1-Antihistamines in Patients with Chronic Spontaneous Urticaria
by: Clara Matei, et al.
Published: (2021-07-01)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
by: Wang XY, et al.
Published: (2016-04-01)

Awareness of family physicians towards antihistamines
by: Sumaya Zeerak, et al.
Published: (2019-01-01)

A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown‐CSU study
by: Murat Türk, et al.
Published: (2024-02-01)

Evidence for histamine release in chronic inducible urticaria – A systematic review
by: Kanokvalai Kulthanan, et al.
Published: (2022-07-01)

Efficacy and safety of total glucosides of paeony as an add-on treatment in adolescents and adults with chronic urticaria: A systematic review and meta-analysis
by: Ming Li, et al.
Published: (2022-09-01)

Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria
by: Mohammed Shanshal
Published: (2022-02-01)

Efficacy and safety of acupuncture for patients with chronic urticaria: study protocol of a randomized, sham-controlled pilot trial
by: Yunzhou Shi, et al.
Published: (2019-06-01)

Autologous Whole Blood Therapy in Chronic Spontaneous Urticaria: A Comparative Study Between Autologous Serum Skin Test Positive and Negative Patients
by: Manjunath V Marigeri, et al.
Published: (2023-04-01)

Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
by: Atsushi Fukunaga, et al.
Published: (2020-01-01)

Efficacy of increased dose of rupatadine up to 20 mg on itching in Japanese patients due to chronic spontaneous urticaria, dermatitis, or pruritus: A post hoc analysis of phase III clinical trial
by: Michihiro Hide, et al.
Published: (2019-10-01)

Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials
by: Cheng-zhi Huang, et al.
Published: (2019-11-01)

Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study
by: Michihiro Hide, et al.
Published: (2017-04-01)

Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
by: Ignacio J. Ansotegui, et al.
Published: (2022-05-01)

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
by: Jingjing Wei, et al.
Published: (2022-04-01)

The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria
by: A. A. Kubanov, et al.
Published: (2017-08-01)

Epidemiological and Clinical Characteristics of Adult and Pediatric Patients with Chronic Spontaneous Urticaria
by: Aviv Barzilai, et al.
Published: (2023-12-01)

Urticaria and angioedema
by: Amin Kanani, et al.
Published: (2018-09-01)